Mucus and inflammation in the HEMT Era: Persistent barriers to complete airway normalization in cystic fibrosis
Journal of Cystic Fibrosis · 2026-03
DOI: 10.1016/j.jcf.2026.03.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cystic Fibrosis, 2026-03. Verfasst von Camille Ehre und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Marsico Lung Institute, University of North Carolina at …. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Cystic fibrosis (CF) is an epithelial ion transport disorder that dehydrates the airway surface, concentrates mucus, and disrupts mucociliary clearance (MCC). Beyond reduced chloride/bicarbonate secretion and elevated ENaC activity, shifts in the composition, structure, and packaging of the gel-forming mucins MUC5AC and MUC5B reshape mucus viscoelasticity and adhesion, promoting stasis, infection, and inflammation. We synthesize mechanistic advances showing how CFTR dysfunction and microenvironmental cues, particularly epithelial hypoxia with HIF-driven ENaC activation and IL-1 cytokine signaling, reinforce hyperconcentration, alter MUC5AC/MUC5B balance, impede submucosal gland discharge, and foster a self-perpetuating cycle of protease-rich inflammation. Highly effective CFTR modulator therapies, such as elexacaftor/tezacaftor/ivacaftor, improve hydration, MCC, and inflammation; however, residual rheologic abnormalities, inflammation, persistent or recurrent infection, and regional heterogeneity are common, indicating that CFTR restoration alone does not uniformly normalize the airway milieu. We highlight methodological advances that enable quantitative, surface-level readouts in patient-derived air-liquid-interface cultures (e.g., FRAP and magnetic micro-wire rheology) linking thin-layer mucus viscosity, network mechanics, and transport to cellular physiology. Integrating these assays with clinical measures (e.g., MCC, segmental pathogen and protease burden) supports a comprehensive model in which CFTR loss initiates mucus hyperconcentration that is subsequently enhanced by mucin entanglement/interactions and hypoxia-inflammatory feedback. Finally, we propose an integrated therapeutic framework that pairs CFTR correction with mechanism-guided, mucus-targeted interventions and data-driven anti-infective/anti-inflammatory strategies to optimize personalized treatment approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Microbiology and Immu…
- Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Center for Child and Adolescent Health (DZKJ), partner site Berlin, Berl…
- Irish Centre for Genetic Lung Disease, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- National Heart Lung and Blood Institute
- National Institutes of Health
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Forschung, Technologie und Raumfahrt
- Cook Family Foundation
- Bundesministerium fur Wirtschaft und Technologie
Zitieren
APA
Ehre, C., Mall, M. A., & McElvaney, G. N. (2026). Mucus and inflammation in the HEMT Era: Persistent barriers to complete airway normalization in cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2026.03.010
Vancouver
Ehre C, Mall MA, McElvaney GN. Mucus and inflammation in the HEMT Era: Persistent barriers to complete airway normalization in cystic fibrosis. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2026.03.010
BibTeX
@article{Ehre2026,
author = {Ehre, Camille and Mall, Marcus A and McElvaney, Gerard N},
title = {Mucus and inflammation in the HEMT Era: Persistent barriers to complete airway normalization in cystic fibrosis},
journal = {Journal of Cystic Fibrosis},
year = {2026},
doi = {10.1016/j.jcf.2026.03.010}
}
EUVIMED